Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Submitted by
admin
on May 29, 2013 - 4:49pm
Source:
Fierce Biotech
News Tags:
FDA
GSK
melanoma
dabrafenib
trametinib
Headline:
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Do Not Allow Advertisers to Use My Personal information
